Zeskind Benjamin J.

PRESIDENT AND CEO, Director, 10% OwnerImmuneering Corp (IMRX) · full profile →Form 4 · filed Jul 3, 2025
Net Buying
Open-Market Buys
$35K
Open-Market Sells
$0
Net Open-Market Flow
$35K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 2, 2025Buy(P)7K$3.53$25K2.3M
Jul 1, 2025Buy(P)3K$3.38$10K2.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001790340-25-000094) within minutes of acceptance. Every field above traces to the original document. Verify it directly: